Table 1.
Clinical and demographical characteristics of 392 patients from the regional register for neurostimulation treatment in western Norway receiving ECT for depression
| Characteristics | ||
|---|---|---|
| Sex, female, n (%) | 238 | (60.7) |
| Age in years, M (SD) | 54.8 | (17.6) |
| Previously received ECT, n (%) | 90 | (23.0) |
| Age at debut affective symptoms, M (SD) | 35.7 | (19.5) |
| Family history of severe psychiatric disorders a, n (%) | 219 | (63.1) |
| Duration of current episode (weeks), M (SD) | 31.2 | (56.9) |
| Bipolar disorder, n (%) | 83 | (21.2) |
| Depression severity b | ||
| Moderate, n (%) | 57 | (14.5) |
| Severe without psychotic features, n (%) | 215 | (54.8) |
| Severe with psychotic features, n (%) | 120 | (30.6) |
| Medication at first ECT-session c | ||
| Antidepressant, n (%) | 275 | (70.2) |
| Antipsychotic, n (%) | 251 | (64.0) |
| Benzodiazepine/z-drug, n (%) | 69 | (17.6) |
| Anticonvulsant, n (%) | 22 | (5.6) |
| Lithium, n (%) | 24 | (6.1) |
| No psychotropic medication, n (%) | 43 | (11.0) |
Abbreviation: ECT, electroconvulsive therapy.
Note: Percentages reported are valid percent.
a
History of first- or second-degree relatives suffering from severe depression, bipolar disorder, or schizophrenia.
b
Based on registered diagnosis, including both uni- and bipolar depression.
c
Administered on a regular basis.